Evolent Health Inc [EVH] stock is trading at $4.27, up 3.14%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EVH shares have gain 10.34% over the last week, with a monthly amount drifted -45.33%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolent Health Inc [NYSE: EVH] stock has seen the most recent analyst activity on November 13, 2025, when Stephens upgraded its rating to an Overweight but kept the price target unchanged to $7 for it. Previously, BMO Capital Markets started tracking the stock with Outperform rating on November 13, 2025, and set its price target to $7. On January 10, 2025, Needham initiated with a Buy rating and assigned a price target of $15 on the stock. BTIG Research reiterated its Buy rating and decreased its price target to $29 on December 03, 2024. Stephens downgraded its rating to a Equal-Weight and reduced its price target to $16 on November 08, 2024. KeyBanc Capital Markets started tracking with an Overweight rating for this stock on October 11, 2024, and assigned it a price target of $35. In a note dated August 09, 2024, Truist upgraded a Buy rating on this stock and boosted its target price from $28 to $33.
Evolent Health Inc [EVH] stock has fluctuated between $3.49 and $13.61 over the past year. Currently, Wall Street analysts expect the stock to reach $31.11 within the next 12 months. Evolent Health Inc [NYSE: EVH] shares were valued at $4.27 at the most recent close of the market. An investor can expect a potential return of 628.57% based on the average EVH price forecast.
Analyzing the EVH fundamentals
Evolent Health Inc [NYSE:EVH] reported sales of 2.05B for the trailing twelve months, which represents a drop of -22.83%. Gross Profit Margin for this corporation currently stands at -0.06% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.08%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.15 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.04 points at the first support level, and at 3.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.53, and for the 2nd resistance point, it is at 4.78.
Ratios To Look Out For
For context, Evolent Health Inc’s Current Ratio is 1.33. Further, the Quick Ratio stands at 1.33, while the Cash Ratio is 0.27. Considering the valuation of this stock, the price to sales ratio is 0.23, the price to book ratio is 0.57.
Transactions by insiders
Recent insider trading involved Springstubb Brendan B, Director, that happened on Nov 18 ’25 when 10000.0 shares were purchased. Director, Holder Diane completed a deal on Mar 06 ’25 to buy 2735.0 shares. Meanwhile, PRESIDENT McCarthy Daniel Joseph bought 11040.0 shares on Mar 06 ’25.
